{"denoms":[{"counts":[{"groupId":"BG000","value":"74"}],"units":"Participants"}],"groups":[{"description":"Patients receive 3 cycles (1 cycle = 21 days) of neoadjuvant chemotherapy (800 mg/m\\^2 of gemcitabine IV and 80 mg/m\\^2 of Paclitaxel IV on days 1 and 8 and Carboplatin IV on day 1), TURBT within 4-8 weeks of chemotherapy, option of proceeding with immediate cystectomy or observation.","id":"BG000","title":"Gemcitabine, Paclitaxel, Carboplatin Followed by Surgery"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"49","upperLimit":"83","value":"69"}]}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Age Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"18"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"56"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"3"}],"title":"Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"55"}],"title":"Not Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"16"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Ethnicity (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"1"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"0"}],"title":"Native Hawaiian or Other Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"2"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"70"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"0"}],"title":"More than one race"},{"measurements":[{"groupId":"BG000","value":"0"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"50"}]}],"title":"0"},{"categories":[{"measurements":[{"groupId":"BG000","value":"16"}]}],"title":"1"},{"categories":[{"measurements":[{"groupId":"BG000","value":"8"}]}],"title":"Missing"}],"description":"Patients will be graded according to the Zubrod performance status scale. 0: Fully active, able to carry all pre-disease performance without restriction. 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. 2: Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours. 3: Capable of limited self-care, confined to bed or chair more than 50% of waking hours. 4: Completely disabled; cannot carry on any self-care; totally confined to bed or chair.","paramType":"NUMBER","title":"Performance Status","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"52"}]}],"title":"T2"},{"categories":[{"measurements":[{"groupId":"BG000","value":"17"}]}],"title":"T3"},{"categories":[{"measurements":[{"groupId":"BG000","value":"5"}]}],"title":"T4a"}],"description":"Primary Tumor (T): TX Primary tumor cannot be assessed, T0 No evidence of primary tumor, Ta Non-invasive papillary carcinoma, Tis Carcinoma in situ: \"flat tumor\", T1 Tumor invades subepithelial connective tissue, T2 Tumor invades muscle, pT2a Tumor invades superficial muscle (inner half), pT2b Tumor invades deep muscle (outer half), T3 Tumor invades perivesical tissue, pT3a Microscopically, pT3b Macroscopically (extravesical mass), T4 Tumor invades any of the following: prostate, uterus, vagina, pelvic wall, abdominal wall, T4a Tumor invades prostate, uterus, vagina.","paramType":"NUMBER","title":"Clinical T Stage","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"11"}]}],"title":"Yes"},{"categories":[{"measurements":[{"groupId":"BG000","value":"59"}]}],"title":"No"},{"categories":[{"measurements":[{"groupId":"BG000","value":"4"}]}],"title":"Missing"}],"paramType":"NUMBER","title":"Prior Intravesical Therapy","unitOfMeasure":"participants"}]}